3rd Quarter - Report
DENTONS US LLP for ADAPT PHARMA
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues surrounding nasal Naloxone for emergency treatment of opioid overdose; S. 524, Comprehensive Addiction and Recovery Act (CARA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENIFER HEALY | Professional Staff, Senate Foreign Relations; Health Counsel, Sen. Bob Corker; LA, Sen. Kay Bailey Hutchinson; Health Policy Advisor, Rep. Sam Johnson; LA, Rep. Phil Gingrey; LC, Rep. Mark Green |
| MARK WELLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.